| Assessment Status | Rapid Review complete |
| HTA ID | - |
| Drug | Corifollitropin alfa |
| Brand | Elonva® |
| Indication | Controlled Ovarian Stimulation (COS) in combination with a Gonadotropin Releasing Hormone (GnRH) antagonist for the development of multiple follicles in women participating in an Assisted Reproductive Technology (ART) program. |
| Assessment Process | |
| Rapid review commissioned | 22/09/2010 |
| Rapid review completed | 22/10/2010 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended. |